Synthonics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synthonics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10612
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synthonics Inc (Synthonics) is a pharmaceutical company that discovers, develops and licenses metal coordinated pharmaceuticals. The company uses unique metal coordination chemistry for modifying specific properties of patent-expiring pharmaceuticals. It develops MCP-311, a drug candidate that provides solution to extend the absorption phase of levodopa using the bioadhesive properties of a bismuth-levodopa copolymer. Synthonics’ patent applications include bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients; metal coordinated compositions; and coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients. The company works in partnership with other pharmaceutical companies to advance the development of novel drugs. Synthonics is headquartered in Blacksburg, Virginia, the US.

Synthonics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthonics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synthonics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthonics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Synthonics Raises USD0.5 Million in Venture Financing 10
Partnerships 11
Recipharm Enters into Agreement with Synthonics 11
Recipharm Enters Into Co-Promotion Agreement With Synthonics 12
Equity Offering 13
Synthonics Raises USD2 Million in Private Placement of Preferred Shares 13
Synthonics Inc – Key Competitors 14
Synthonics Inc – Key Employees 15
Synthonics Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Synthonics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthonics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthonics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Synthonics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthonics Raises USD0.5 Million in Venture Financing 10
Recipharm Enters into Agreement with Synthonics 11
Recipharm Enters Into Co-Promotion Agreement With Synthonics 12
Synthonics Raises USD2 Million in Private Placement of Preferred Shares 13
Synthonics Inc, Key Competitors 14
Synthonics Inc, Key Employees 15

List of Figures
Synthonics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthonics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synthonics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biom’Up SAS (BUP):医療機器:M&Aディール及び事業提携情報
    Summary Biom'Up SAS (Biom'Up) is a medical device company that designs, develops and manufactures collagen-based absorbable medical devices for biosurgery. The company's products include covamesh, hemosnow, hemoblast bellows, cova and matri bone, among others. It offers collagens, resorbable polymer …
  • Becker Avionics, Inc.:企業の戦略・SWOT・財務情報
    Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Institut Gustave Roussy-製薬・医療分野:企業M&A・提携分析
    Summary Institut Gustave Roussy (IGR) is a cancer research institute that offers healthcare services to patients suffering from cancer and conducts research to identify new therapies. The institute provides treatment for the diseases that include endocrine tumours, childhood cancer, gynecological ca …
  • Orchid Pharma Ltd (ORCHIDPHAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Immune Design Corp (IMDZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Immune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company develops its product candidates through its ZVex and GLAAS discovery platforms. Immune Design’s p …
  • Dawnbreaker, Inc.:企業の戦略・SWOT・財務分析
    Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Brown Brothers Harriman & Co:企業の戦略的SWOT分析
    Brown Brothers Harriman & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務分析
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, photography, creative and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • Cleco Corporate Holdings LLC:発電所・企業SWOT分析
    Cleco Corporate Holdings LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務分析
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Airports of Thailand Plc (AOT):企業の財務・戦略的SWOT分析
    Airports of Thailand Plc (AOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の財務・戦略的SWOT分析
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. EyePoint dura …
  • GMR Infrastructure Ltd (GMRINFRA):電力:M&Aディール及び事業提携情報
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Group, is a construction company. The company executes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv Gandhi Inter …
  • Marubeni Corp (8002):石油・ガス:M&Aディール及び事業提携情報
    Summary Marubeni Corp (Marubeni) is an integrated trading and investment business that operates through its domestic and overseas subsidiaries. It provides various products and commodities such as agri and marine products, chemicals, energy, metals and minerals, machinery, textiles, forest products …
  • China Gas Holdings Ltd (384):企業の財務・戦略的SWOT分析
    China Gas Holdings Ltd (384) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BrainLAB AG:企業の戦略的SWOT分析
    BrainLAB AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SPX Corp (SPXC):企業の財務・戦略的SWOT分析
    SPX Corp (SPXC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Storopack Hans Reichenecker GmbH:企業の戦略的SWOT分析
    Storopack Hans Reichenecker GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆